MedicalSystem Biotechnology Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -5.86% vs 10.27% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 906.06% vs -87.21% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "376.00",
          "val2": "399.40",
          "chgp": "-5.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "24.30",
          "val2": "-7.10",
          "chgp": "442.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "1.00",
          "chgp": "-80.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.80",
          "val2": "0.70",
          "chgp": "14.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "33.20",
          "val2": "3.30",
          "chgp": "906.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "64.70%",
          "val2": "-17.70%",
          "chgp": "8.24%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -7.48% vs -24.39% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 1.23% vs 26.46% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,735.60",
          "val2": "1,875.90",
          "chgp": "-7.48%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "455.90",
          "val2": "437.50",
          "chgp": "4.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.70",
          "val2": "10.90",
          "chgp": "-75.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-13.30",
          "val2": "-14.50",
          "chgp": "8.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "262.70",
          "val2": "259.50",
          "chgp": "1.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "134.30%",
          "val2": "134.70%",
          "chgp": "-0.04%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Sep'25

Change(%)

Net Sales

376.00

399.40

-5.86%

Operating Profit (PBDIT) excl Other Income

24.30

-7.10

442.25%

Interest

0.20

1.00

-80.00%

Exceptional Items

0.80

0.70

14.29%

Consolidate Net Profit

33.20

3.30

906.06%

Operating Profit Margin (Excl OI)

64.70%

-17.70%

8.24%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -5.86% vs 10.27% in Sep 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 906.06% vs -87.21% in Sep 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

1,735.60

1,875.90

-7.48%

Operating Profit (PBDIT) excl Other Income

455.90

437.50

4.21%

Interest

2.70

10.90

-75.23%

Exceptional Items

-13.30

-14.50

8.28%

Consolidate Net Profit

262.70

259.50

1.23%

Operating Profit Margin (Excl OI)

134.30%

134.70%

-0.04%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -7.48% vs -24.39% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 1.23% vs 26.46% in Dec 2023

All Annual Results